Prof Duk Woo Park
Prof Duk-Woo Park is an interventional cardiologist and researcher at Asan Medical Center, Seoul, with over 400 publications and expertise in coronary revascularisation, valvular interventions, and antithrombotic strategy.
Prof Duk-Woo Park
Dr Park Duk-Woo s an interventional cardiologist at Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Prof Park graduated and earned MD from University of Kyoung-Hee Medical College, Seoul, Korea. His postgraduate training was spent with an internship and residency at Asan Medical Center. He also completed fellowships in cardiovascular medicine and interventional cardiology at Asan Medical Center. He has experienced research fellowship (as a visiting scholar) at the Duke Clinical Research Institute (Durham, NC, USA).
He is now professor of division of cardiology and a director of interventional catheterization laboratory, Asan Medical Center as well as program director and co-chair of annual TCTAP, AP-Valve, and Complex PCI international meeting.
Prof Park has been the principal investigator (PI) or Co-PI investigators of the MAINCOMPARE, DES-LATE (ZEST-LATE/REAL-LATE), PRECOMBAT, BEST, POST-PCI, PREVENT, and EPIC-CAD trials, which were published in NEJM. He had more than 400 scientific publications as primary and contributing authors: among them, he had more than 40 top-cardiology journal publications as a primary author (corresponding or first author) (4 NEJM, 1 Lancet, 1 JAMA, 25 JACC, 8 Circulation, 3 EHJ). He was awarded with Douglas P. Zipes Distinguished Young Scientist Award at the 2012 ACC, Chicago, IL. His primary research interest has been in left main PCI, coronary revascularization strategy (PCI or CABG), antithrombotic strategy, coronary device, valvular interventions (TAVR), biomarker research, and outcome research.
Prof Park was a chief scientific director of KSIC (Korean Society of Interventional Cardiology) and is now a Deputy Editor in JACC Asia.